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High quinolone resistance rates were observed among oxyiminocephalosporin-resistant enterobacteria. In the 
present study, we searched for the prevalence of plasmid-mediated quinolone resistance (PMQR) genes within the 
55 oxyiminocephalosporin-resistant enterobacteria collected in a previous survey. The main PMQR determinants 
were aac(6’)-Ib-cr and qnrB, which had prevalence rates of 42.4% and 33.3%, respectively. The aac(6’)-Ib-cr gene 
was more frequently found in CTX-M-15-producing isolates, while qnrB was homogeneously distributed among all 
CTX-M producers.
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Quinolone resistance in Gram-negative bacilli is pri-
marily related to mutations in the chromosomal genes 
encoding for type II topoisomerases, the target site of 
quinolones (Drlica & Zhao 1997). However, in 1998, the 
first plasmid-mediated quinolone resistance (PMQR) de-
terminant, qnrA, was reported in a Klebsiella pneumoniae 
strain. Since then, four additional qnr determinants, qnrB, 
qnrC, qnrD and qnrS, have been identified in Enterobac-
teriaceae species and some of these determinants have 
several allelic variants (Rodriguez-Martinez et al. 2011). 
These determinants encode for a pentapeptide repeat pro-
tein that binds to DNA gyrase, protecting the DNA gyrase 
from quinolone-mediated inhibition and increasing the 
minimum inhibitory concentrations (MICs) of the quino-
lones by eight-64-fold (Rodriguez-Martinez et al. 2011).
In addition to the qnr genes, various new PMQR 
genes have been discovered during the past decade, 
including the modified acetyltransferase aac(6’)-Ib-cr 
and the efflux pumps qepA and oqxAB (Rodriguez-
Martinez et al. 2011).
The association of PMQR genes with extended-spec-
trum β-lactamases (ESBLs) and AmpC β-lactamases 
is note worthy (Canton & Coque 2006). Although a 
few studies describing PMQR determinants in selected 
isolates have been performed, these associations have 
not been previously studied in Argentina (Quiroga et 
al. 2007, Jacoby et al. 2009, Andres et al. 2013). This 
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study aimed to investigate the prevalence of PMQR 
genes (qnrA, -B, -S, -C and -D, aac(6)-Ib-cr and qepA) 
in oxyiminocephalosporin-resistant Enterobacteriaceae 
recovered during a recent multicentre survey conducted 
in Argentina (Sennati et al. 2012). In addition, we also 
examined the coexistence of these determinants with 
different ESBL and/or AmpC β-lactamases.
The surveillance study was performed during Oc-
tober 2010 in 15 community hospitals distributed in 
three different regions of Argentina. Samples from both 
inpatients and outpatients were included. From 1,586 
consecutive and non-repetitive enterobacterial clinical 
isolates recovered during this period, 207 (13.05%) dis-
played reduced susceptibility to expanded-spectrum ce-
phalosporins (ESC) (Sennati et al. 2012). Antimicrobial 
susceptibility tests were performed by dilution and dif-
fusion methods according to the Clinical and Laboratory 
Standards Institute (CLSI) for ampicillin, amoxicillin–
clavulanic acid, piperacillin/tazobactam, cephalothin, 
cefoxitin, cefotaxime, ceftazidime, cefotaxime/clavu-
lanic acid, ceftazidime/clavulanic acid, cefepime, imi-
penem, meropenem, amikacin, gentamicin, tobramycin, 
nalidixic acid, ciprofloxacin, levofloxacin and gatiflox-
acin (CLSI/NCCLS 2010). Molecular epidemiology of 
PMQR determinants was conducted for all confirmed 
ESC-resistant isolates (n = 55) collected during the first 
week of the study (22 K. pneumoniae, 16 Escherichia 
coli, 6 Proteus mirabilis, 4 Klebsiella oxytoca, 3 Serra-
tia spp, 3 Enterobacter spp and 1 Providencia sp.) (Sen-
nati et al. 2012). This sample was considered to be repre-
sentative of the entire study period because the relative 
frequency of the most prevalent species was similar 
throughout the study period.
Molecular detection of qnrA, qnrB, qnrC, qnrD and 
qnrS was carried out by polymerase chain reaction 
(PCR) amplification using total heat-extracted DNA as a 
template and primers previously described (Cattoir et al. 
PMQR genes in Enterobacteriaceae • Giovanna Rincon Cruz et al. 925
2007, Cavaco et al. 2009, Wang et al. 2009). For further 
characterisation of qnrB alleles, the following primers 
were designed (5’-3’): QnrBcF: GTTRGCGAAAAAAT-
TRACAG, QnrBlF: ATGWYGYCATTATGTATA and 
QnrBcR: CCMATHAYMGCGATRCCAAG. All qnrB 
amplicons were sequenced on both strands using an ABI 
PRISM 3700 DNA sequencer. Screening for the aac(6’)-
Ib gene was performed using the following primers 
(5’-3’): aac(6’)IbF: CGATCTCATATCGTCGAGTG and 
aac(6’)IbR: TTAGGCATCACTGCGTGTTC. Charac-
terisation of the aac(6’)-Ib-cr variant was conducted 
by restriction fragment length polymorfism-PCR us-
ing BseGI (Fermentas, Thermo Fisher Scientific Inc, 
Massachusetts, USA) (Park et al. 2006) and sequenc-
ing. The presence of the qepA gene was investigated by 
PCR amplification using the following primers (5’-3’): 
qepAF: ACATCTACGGCTTCTTCGTCG and qepAR: 
AACGCTTGAGCCCGTAGATC.
The 55 ESC-resistant isolates investigated in this 
study included 50 ESBL producers and the remaining 
five isolates were strong producers of AmpC. Among 
the ESBL-positive isolates, 47 were CTX-M producers 
(94%), with the most prevalent enzymes produced being 
CTX-M-2 (44%) and CTX-M-15 (38%) and to a lesser 
extent CTXM-14 (3/50), PER-2 (3/50), SHV-12 (2/50), 
SHV-5 (2/50), CTX-M-8 (1/50) and CTX-M-56 (1/50). 
Three isolates encoded two different ESBLs simultane-
ously. Susceptibility to nalidixic acid and ciprofloxacin 
was 7.3% and the susceptibility rate of isolates to either 
levofloxacin or gatifloxacin was 23.6%. Gentamicin, 
amikacin and tobramycin displayed susceptibility rates 
of 43.6%, 61.8% and 23.6%, respectively. The MIC50 and 
MIC90 values of the fluoroquinolones were higher for 
PMQR-positive K. pneumoniae isolates (data not shown). 
However, no differences in MIC values were observed 
within E. coli isolates.
High diversity of PMQR genes was found among 
these enterobacteria. Sixty-six percent (33/50) of ESBL-
producing isolates had at least one PMQR determinant 
(Table). In contrast, no PMQR genes were detected in iso-
lates that produced high levels of AmpC (2 E. coli and 1 
P. mirabilis harbouring CMY-2 and 2 Enterobacter spp).
Among the PMQR-positive isolates, 42.4% (14/33) 
and 33.3% (11/33) encoded either aac(6’)-Ib-cr or qnrB 
as a determinant of quinolone resistance respectively, 
while 24.3% (8/33) had both determinants. No isolates 
rendered a positive amplification of qnrA, qnrS, qnrC, 
qnrD or qepA.
Five qnrB variants were found in this study; qnrB2-
like was the most prevalent (8/19), followed by qnrB19-like 
(6/19), qnrB10-like (3/19), qnrB1-like (1/19) and qnrB6-
like (1/19). A homogeneous distribution of qnrB variants 
among CTX-M producers was observed (Table).
The aac(6’)-Ib-cr gene was detected in 44% (22/50) 
of the ESBL-producing isolates, displaying similar per-
centages for both E. coli (56.2%, 9/16) and K. pneumo-
niae (54.5%, 12/22). However, aac(6’)-Ib-cr was mainly 
associated with CTX-M-15-producing Enterobacteri-
aceae (15/19) and to a lesser extent with other CTX-Ms, 
including CTX-M-2 (5), CTX-M-15/CTX-M-2 (1), CTX-
M-14 (1) and CTX-M-8 (1). One of these 22 aac(6’)-Ib-
cr-harbouring isolates (K. pneumoniae CV1) also car-
ried the wild-type aac(6’)-Ib gene coupled to qnrB19 and 
both CTX-M-2 and CTX-M-15.
We focused on the relationship between the isolates 
that harboured both the aac(6’)-Ib-cr and blaCTX-M-15 de-
terminants. Different clones were observed among the E. 
coli (7) and K. pneumoniae (8) isolates (Table). Phyloge-
netic analysis (Clermont et al. 2000) grouped the E. coli 
isolates into groups A (2) and B2 (5). Isolates belonging 
to the phylogenetic group B2 displayed a similar band-
ing profile by REP-PCR and were characterised as ST131 
according to the MLST Database (mlst.ucc.ie/mlst/dbs/
Ecoli), corresponding with the worldwide pandemic clone 
known to cause nosocomial and community-acquired in-
fections. Additionally, four/eight K. pneumoniae isolates 
were grouped into the same cluster (Kp1) and two of 
these isolates also possessed the qnrB2 allele. According 
to MLST analysis (Diancourt et al. 2005), seven/eight K. 
pneumoniae isolates were typed as ST11 (Table).
The true prevalence of PMQR genes is underesti-
mated because there are no reliable phenotypic methods 
to detect their presence; however, previous surveillance 
reports have shown the prevalence of PMQR determi-
nants among ESBL producers (Cremet et al. 2011, Walsh 
& Rogers 2012). Reports on contemporary isolates in 
Latin American countries displayed conflicting results. 
Nevertheless, comparisons between these studies should 
be performed carefully due to the different bacterial se-
lection criteria used. In concordance with a multicentre 
study performed in Mexico (Silva-Sanchez et al. 2011), 
we observed a high frequency of qnrB and aac(6’)-Ib-
cr genes amongst ESBL-producing isolates. However, a 
very low proportion of these markers were detected in 
Enterobacteriaceae isolated in a paediatric hospital in 
Uruguay (Garcia-Fulgueiras et al. 2011). Furthermore, 
these PMQR genes have also been detected in clinical 
enterobacteria, with unusual phenotypes of quinolone 
susceptibility collected in Argentina. Compared to this 
study, another study reported a different distribution in 
the qnrB allelic variants and the presence of different 
determinants (Andres et al. 2013). 
The present study highlights a putative association 
between aac(6’)-Ib-cr and blaCTX-M-15 and a more homog-
enous distribution of qnrB alleles among ESBL-produc-
ing E. coli and K. pneumoniae.
Notably, some PMQR determinants have been de-
scribed in multiresistant clones with worldwide distribu-
tion (Woodford et al. 2011), such as E. coli ST131 and 
K. pneumoniae ST11, which were also detected in the 
present study, further underscoring the ability of these 
resistance mechanisms to disseminate.
In conclusion, this study is the first report the preva-
lence of PMQR genes in ESBL-producing Enterobac-
teriaceae in Argentina and suggests that the qnrB and 
aac(6’)-Ib-cr genes are widely dispersed among Ente- 
robacteriaceae, as found in many other countries. These 
isolates showed high-level quinolone resistance ESC 
resistance that was mediated by ESBLs; therefore, this 
study demonstrates the importance of understanding the 
potential risk associated with empirical treatment using 
these antibiotic families.
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